Wikidata entity: Q412496
C₂₀H₂₄N₂O₂ (P274)
Quantities
| P4250 | defined daily dose | 1.2 |
| P2067 | mass | 324.184 |
| P2101 | melting point | 170 |
| P233 | canonical SMILES | String | COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O | ??? |
| P373 | Commons category | String | Quinidine | ??? |
| P1889 | different from | ... | Q189522 (quinine) | quinine |
| P703 | found in taxon | ... | Q160090 (Cinchona) | Cinchona |
| P703 | found in taxon | ... | Q164574 (Cinchona pubescens) | Cinchona pubescens |
| P703 | found in taxon | ... | Q3091779 (Cinchona officinalis) | Cinchona officinalis |
| P703 | found in taxon | ... | Q3706791 (Diaporthe) | Diaporthe |
| P703 | found in taxon | ... | Q4808028 (Aspidosperma excelsum) | Aspidosperma excelsum |
| P703 | found in taxon | ... | Q15399753 (Cinchona calisaya) | Cinchona calisaya |
| P703 | found in taxon | ... | Q15400776 (Ciliosemina pedunculata) | Ciliosemina pedunculata |
| P703 | found in taxon | ... | Q18077769 (Aspidosperma marcgravianum) | Aspidosperma marcgravianum |
| P703 | found in taxon | ... | Q104096223 (Cinchona robusta) | Cinchona robusta |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q59199015 (group of stereoisomers) | group of stereoisomers |
| P2017 | isomeric SMILES | String | COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83283320 (LiverTox toxicity likelihood category A) | LiverTox toxicity likelihood category A |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P129 | physically interacts with | ... | Q21096394 (Potassium voltage-gated channel subfamily A member 5) | Potassium voltage-gated channel subfamily A member 5 |
| P129 | physically interacts with | ... | Q21107890 (Potassium voltage-gated channel subfamily A member 7) | Potassium voltage-gated channel subfamily A member 7 |
| P129 | physically interacts with | ... | Q21110532 (Potassium voltage-gated channel subfamily H member 1) | Potassium voltage-gated channel subfamily H member 1 |
| P129 | physically interacts with | ... | Q21119831 (Potassium voltage-gated channel subfamily H member 5) | Potassium voltage-gated channel subfamily H member 5 |
| P129 | physically interacts with | ... | Q21134814 (Solute carrier family 29 member 4) | Solute carrier family 29 member 4 |
| P129 | physically interacts with | ... | Q21497874 (Potassium channel, subfamily U, member 1) | Potassium channel, subfamily U, member 1 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q3791612 (ibutilide) | ibutilide |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P9989 | stylized name | String | quiNIDine | ??? |
| P279 | subclass of | ... | Q27166974 ([(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol) | [(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxy-4-quinolinyl)methanol |
| P2868 | subject has role | ... | Q241549 (antiarrhythmic agent) | antiarrhythmic agent |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2868 | subject has role | ... | Q521616 (antimalarial) | antimalarial |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P2868 | subject has role | ... | Q1927838 (alpha blocker) | alpha blocker |
| P2868 | subject has role | ... | Q3001265 (muscarinic antagonist) | muscarinic antagonist |
| P2868 | subject has role | ... | Q50430448 (voltage-gated sodium channel blockers) | voltage-gated sodium channel blockers |
| P2868 | subject has role | ... | Q50430508 (cytochrome P-450 CYP2D6 inhibitors) | cytochrome P-450 CYP2D6 inhibitors |
Why not click here or view trends?
log id: 2663331